1. Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy 2022; 77: 734-66.
2.
Kulthanan K, Tuchinda P, Chularojanamontri L, et al. Clinical practice guideline for diagnosis and management of urticaria. Asian Pac J Allergy Immunol 2016; 34: 190-200.
3.
Kanani A, Betschel SD, Warrington R. Urticaria and angioedema. Allergy Asthma Clin Immunol 2018; 14 (Suppl 2): 59.
4.
Wertenteil S, Strunk A, Garg A. Prevalence estimates for chronic urticaria in the United States: a sex- and age-adjusted population analysis. J Am Acad Dermatol 2019; 81: 152-6.
5.
Sánchez-Borges M, Ansotegui IJ, Baiardini I, et al. The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management. World Allergy Organ J 2021; 14: 100533.
6.
Badura-Brzoza K, Brzoza Z. Angioedema coexisting chronic spontaneous urticaria negatively influences patients’ sense of coherence, what results in susceptibility to anxiety symptoms occurrence. J Clin Med 2021; 10 : 2852.
7.
Desmond Mandel V, Alicandro T, Pepe P, et al. Chronic spontaneous urticaria: a review of pathological mechanisms, diagnosis, clinical management, and treatment. European Med J 2020; 5: 29-39.
8.
Pozderac I, Lugović-Mihiæ L, Artuković M, et al. Chronic inducible urticaria: classification and prominent features of physical and non-physical types. Acta Dermatovenerol Alp Pannonica Adriat 2020; 29: 141-8.
9.
Lapi F, Cassano N, Pegoraro V, et al. Epidemiology of chronic spontaneous urticaria: Results from a nationwide, population-based study in Italy. Br J Dermatol 2016; 174: 996-1004.
10.
Tzur Bitan D, Berzin D, Cohen A. The association of chronic spontaneous urticaria (CSU) with anxiety and depression: a nationwide cohort study. Arch Dermatol Res 2021; 313: 33-9.
11.
Świerczewski K. Komunikat z badań CBOS: Palenie papierosów. Centrum Badania Opinii Społecznej Komunikat z badañ. 2019; 104: 1-1).
12.
Moos J, Moos £, Brzoza Z. Can smoking have a positive effect on the course of certain diseases? A systematic review. Med Sci Pulse 2022; 16: 33-40.
13.
Mishra NC, Rir-sima-ah J, Boyd RT, et al. Nicotine inhibits FceRI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through a7/a9/a10-nicotinic receptors. J Immunol 2010; 185: 588-96.
14.
Nizri E, Irony-Tur-Sinai M, Lory O, et al. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol 2009; 183: 6681-8.
15.
Acer E, Kaya Erdogan H, Yüksel Çanakçı N, et al. The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticaria. Cutan Ocul Toxicol 2019; 38: 5-8.
16.
Song M, Graubard BI, Rabkin CS, et al. Neutrophil-to-lymphocyte ratio and mortality in the United States general population. Sci Rep 2021; 11: 464.
17.
Huang Z, Fu Z, Huang W, et al. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: a meta-analysis. Am J Emerg Med 2020; 38: 641-7.
18.
Kumarasamy C, Sabarimurugan S, Madurantakam RM, et al.
19.
Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer - a protocol for systematic review and meta-analysis. Medicine (United States) 2019; 98: e14834.
20.
Ping YA, Ping LJ, Qiang TW, et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol 2020; 84: 106504.
21.
Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Med Listy 2021; 122: 474-88.
22.
Wu L, Zou S, Wang C, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in Chinese Han population from Chaoshan region in South China. BMC Cardiovasc Disord 2019; 19: 125.
23.
Majnarić LT, Guljaš S, Bosnić Z, et al. Neutrophil-to-lymphocyte ratio as a cardiovascular risk marker may be less efficient in women than in men. Biomolecules 2021; 11: 528.
24.
Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007; 28: 521-74.
25.
Laffont S, Seillet C, Guéry JC. Estrogen receptor-dependent regulation of dendritic cell development and function. Front Immunol 2017; 8: 108.
26.
Zuo L, He F, Sergakis GG, et al. Interrelated role of cigarette smoking, oxidative stress, and immune response in lung inflammation: a review. Front Immunol 2020; 11: 2485.
27.
Bianchi VE. The anti-inflammatory effects of testosterone. J Endocr Soc 2019; 3: 91-107.
28.
Rakhecha B, Agnihotri P, Dakal TC, et al. Anti-inflammatory activity of nicotine isolated from Brassica oleracea in rheumatoid arthritis. Biosci Rep 2022; 42: BSR20211392.
29.
Piao WH, Campagnolo D, Dayao C, et al. Nicotine and inflammatory neurological disorders. Acta Pharmacol Sin 2009; 30: 715-22.
30.
Zhang W, Lin H, Zou M, et al. Nicotine in inflammatory diseases: anti-inflammatory and pro-inflammatory effects. Front Immunol 2022; 13: 826889.
31.
Tulgar YK, Cakar S, Tulgar S, et al. The effect of smoking on neutrophil/lymphocyte and platelet/lymphocyte ratio and platelet indices: a retrospective study. Eur Rev Med Pharmacol Sci 2016; 20: 3112-8.